niacinamide has been researched along with Hepatoblastoma in 5 studies
nicotinamide : A pyridinecarboxamide that is pyridine in which the hydrogen at position 3 is replaced by a carboxamide group.
Hepatoblastoma: A malignant neoplasm occurring in young children, primarily in the liver, composed of tissue resembling embryonal or fetal hepatic epithelium, or mixed epithelial and mesenchymal tissues. (Stedman, 25th ed)
| Excerpt | Relevance | Reference |
|---|---|---|
| "Sorafenib has recently been shown to reduce tumour growth in hepatoblastoma (HB) xenografts." | 7.79 | Effect of sorafenib combined with cytostatic agents on hepatoblastoma cell lines and xenografts. ( Armeanu-Ebinger, S; Dewerth, A; Eicher, C; Ellerkamp, V; Fuchs, J; Hildenbrand, S; Thomale, J; Warmann, SW, 2013) |
| "We report the use of sorafenib and bevacizumab in combination for a patient with recurrent metastatic hepatoblastoma (HB)." | 7.78 | Sorafenib and bevacizumab for recurrent metastatic hepatoblastoma: stable radiographic disease with decreased AFP. ( Cohen, RA; Feusner, JH; Lo, L; Marsh, AM, 2012) |
| "Treatment with sorafenib led to decreased ERK phosphorylation, reduced cell viability and induction of apoptosis in HepT1 and HUH6 cells." | 5.38 | Treatment effects of the multikinase inhibitor sorafenib on hepatoblastoma cell lines and xenografts in NMRI-Foxn1 nu mice. ( Armeanu-Ebinger, S; Dewerth, A; Eicher, C; Fuchs, J; Kirchner, B; Warmann, SW, 2012) |
| "Sorafenib has recently been shown to reduce tumour growth in hepatoblastoma (HB) xenografts." | 3.79 | Effect of sorafenib combined with cytostatic agents on hepatoblastoma cell lines and xenografts. ( Armeanu-Ebinger, S; Dewerth, A; Eicher, C; Ellerkamp, V; Fuchs, J; Hildenbrand, S; Thomale, J; Warmann, SW, 2013) |
| "We report the use of sorafenib and bevacizumab in combination for a patient with recurrent metastatic hepatoblastoma (HB)." | 3.78 | Sorafenib and bevacizumab for recurrent metastatic hepatoblastoma: stable radiographic disease with decreased AFP. ( Cohen, RA; Feusner, JH; Lo, L; Marsh, AM, 2012) |
| "Treatment with sorafenib led to decreased ERK phosphorylation, reduced cell viability and induction of apoptosis in HepT1 and HUH6 cells." | 1.38 | Treatment effects of the multikinase inhibitor sorafenib on hepatoblastoma cell lines and xenografts in NMRI-Foxn1 nu mice. ( Armeanu-Ebinger, S; Dewerth, A; Eicher, C; Fuchs, J; Kirchner, B; Warmann, SW, 2012) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (20.00) | 29.6817 |
| 2010's | 4 (80.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Goto, H | 1 |
| Kitagawa, N | 1 |
| Sekiguchi, H | 1 |
| Miyagi, Y | 1 |
| Keino, D | 1 |
| Sugiyama, M | 1 |
| Sarashina, T | 1 |
| Miyagawa, N | 1 |
| Yokosuka, T | 1 |
| Hamanoue, S | 1 |
| Iwasaki, F | 1 |
| Shiomi, M | 1 |
| Goto, S | 1 |
| Tanaka, Y | 1 |
| Eicher, C | 2 |
| Dewerth, A | 2 |
| Kirchner, B | 1 |
| Warmann, SW | 2 |
| Fuchs, J | 2 |
| Armeanu-Ebinger, S | 2 |
| Marsh, AM | 1 |
| Lo, L | 1 |
| Cohen, RA | 1 |
| Feusner, JH | 1 |
| Thomale, J | 1 |
| Ellerkamp, V | 1 |
| Hildenbrand, S | 1 |
| Yamamoto, H | 1 |
| Ozaki, T | 1 |
| Nakanishi, M | 1 |
| Kikuchi, H | 1 |
| Yoshida, K | 1 |
| Horie, H | 1 |
| Kuwano, H | 1 |
| Nakagawara, A | 1 |
5 other studies available for niacinamide and Hepatoblastoma
| Article | Year |
|---|---|
The Collagen Gel Droplet-embedded Culture Drug Sensitivity Test in Relapsed Hepatoblastoma.
Topics: Antineoplastic Agents; Camptothecin; Cell Line, Tumor; Child; Child, Preschool; Collagen; Drug Scree | 2017 |
Treatment effects of the multikinase inhibitor sorafenib on hepatoblastoma cell lines and xenografts in NMRI-Foxn1 nu mice.
Topics: alpha-Fetoproteins; Animals; Antineoplastic Agents; Apoptosis; Benzenesulfonates; Blotting, Western; | 2012 |
Sorafenib and bevacizumab for recurrent metastatic hepatoblastoma: stable radiographic disease with decreased AFP.
Topics: alpha-Fetoproteins; Angiogenesis Inhibitors; Antibodies, Monoclonal, Humanized; Antineoplastic Agent | 2012 |
Effect of sorafenib combined with cytostatic agents on hepatoblastoma cell lines and xenografts.
Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Cell Line, Tumor; Cell Survival; | 2013 |
Oxidative stress induces p53-dependent apoptosis in hepatoblastoma cell through its nuclear translocation.
Topics: Active Transport, Cell Nucleus; Apoptosis; Carrier Proteins; Cell Line, Tumor; Cell Nucleus; Child; | 2007 |